rHuPH20
| Source | NASEM Database |
|---|---|
| Organization | Halozyme |
| Market status | On the market |
| Industry | Health |
| Value chain stage | Input |
| Intended consumer | Commercial |
| Production process | Closed Production |
| Business models | B2B |
| Product categories | Medical Treatment |
| Biotech components | Enzyme |
| Organization type(s) | Public Company |
| Funding types | Shareholder Investment |
| Country of production | USA |
| Country of distribution | USA |
| Trading symbol | HALO |
| Trading exchange | NASDAQ |
| Notes | Product is designed to aid injection of other enzymes |